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Abstract
Background: To explore the association between atrial fibrillation (AF) and serum uric acid (SUA) in a general
population in rural China.
Methods: From January 2013 to August 2013, we performed a cross-sectional study involving 11,956 permanent
residents ≥ 35 years old in the rural Liaoning province of China. All participants completed a questionnaire, had a
physical examination, and underwent an electrocardiogram (ECG) and echocardiogram. AF was diagnosed from
ECG findings and/or a history of physician-confirmed AF. Blood samples were drawn for laboratory analyses and
hyperuricemia was defined as an SUA level > 7.0 mg/dL in men and > 5.7 mg/dL in women, based on the
NHANES-III laboratory definition. Logistic regression analyses were performed to estimate the crude and
independent associations between hyperuricemia and the prevalence of AF.
Results: A total of 139 participants were diagnosed with AF, of which, 72 were self-reported, 45 were ECG-diagnosed,
and 22 were both. There was a higher prevalence of AF in participants with hyperuricemia than those with normal
SUA levels (2.4 vs. 1.0 %; P < 0.001). The odds ratios (OR) and 95 % confidence intervals (CI) were 2.37 (1.61–3.49) when
compared to participants with normal SUA. After adjustment for other cardiovascular and AF risk factors, the
independent association remained (OR = 1.94, 95 % CI: 1.26–3.00). Similar associations were observed between SUA as
a continuous variable and AF prevalence (adjusted OR = 1.20, 95 % CI: 1.06–1.36). The independent associations were
significant in men (Ps < 0.05) but not in women (Ps > 0.05), although the interaction logistic regression analyses
presented these differences as not being statistically significant (Ps > 0.05).
Conclusions: SUA is positively associated with the prevalence of AF in rural China.
Background
Atrial fibrillation (AF) is one of the most common
cardiac arrhythmias and is associated with overall mor-
tality and mortality from cardiovascular disease [1, 2].
Advancing age, male gender, hypertension, diabetes
mellitus, obesity, heart failure, myocardial infarction
(MI), and alcohol consumption are the major risk fac-
tors for the development of AF [3–6]. The prevalence
of AF is expected to increase dramatically over the next
few decades as the general population ages and im-
proved cardiovascular therapies keep people with car-
diovascular disease alive longer [7]. Identifying all the
risk factors for AF will help to create population-based
strategies to deal with this serious health problem.
Serum uric acid (SUA) is a risk factor for cerebrovas-
cular and coronary artery disease, as well as for hyper-
tension, metabolic syndrome, and kidney disease [8],
though only a few cross-sectional studies in Japan [9],
Turkey [10], and China [11–13] have reported a posi-
tive association between hyperuricemia and the preva-
lence of AF. Also, population-based prospective cohorts
showed that hyperuricemia was associated with a high
risk of AF [14, 15]. However, all of these cross-sectional
studies enrolled hospital patients only rather than indi-
viduals from the general population. Furthermore, only
the study in Japan analyzed the effect of gender on the
association between hyperuricemia and AF, reporting that
the independent association was observed in women only.
Therefore, the current study was designed to explore the
association between SUA and AF in a general population
from rural China. The study also analyzed the effect of
gender on the independent association.
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A representative sample of men and women ≥ 35 years of
age from rural areas of Liaoning Province were recruited
between January 2013 and August 2013 using a multi-
stage, randomly stratified, cluster-sampling scheme. In
particular, three counties (Dawa, Zhangwu, and Liaoyang)
were randomly selected from Liaoning Province. One
township near a city in each county was randomly selected
giving a total of three townships. Six to eight villages from
each township were randomly selected to give a total of
26 rural villages. All of the eligible permanent residents
aged ≥ 35 years from each village (n = 14,016) were invited
to participate in the study, and 11,956 (85.3 %) agreed to
do so; women who were pregnant, or people who had can-
cer or any mental disorders were excluded from the study.
The study was carried out with pre-approval granted
by the Ethics Committee of China Medical University
(Shenyang, China). Written consent was obtained from
all participants after they had been informed of the
study’s objectives, benefits, medical procedures, and
confidentiality safeguards for personal information. In
the case of an illiterate participant, written informed
consent was obtained from the appropriate legal proxy.
Data collection and measurement
Data were collected during a single clinic visit by cardiolo-
gists and trained nurses using a standard questionnaire in
a face-to-face interview. All potential investigators had
received training on the objectives of the study, how to ad-
minister the questionnaire, the standard methods of meas-
urement, the importance of standardization, and study
procedures. Only those who earned a perfect score on a
post-training test were allowed to participate as study
investigators. During data collection, the inspectors re-
ceived further instructions and support.
Data on demographic characteristics and medical his-
tory of AF, MI, hypertension, diabetes mellitus, lifestyle
risk factors, and family history of AF were obtained, as
described above, by interview with the standardized ques-
tionnaire. There was a central steering committee with a
subcommittee for quality control that made sure all data
were collected according to well-known standards.
According to the American Heart Association, blood
pressure (BP) was measured three times at two-minute
intervals after at least five minutes of rest using a
standardized automatic electronic sphygmomanometer
(HEM-907; Omron, Kyoto, Japan). Two doctors checked
the calibration of the Omron device every month using a
standard mercury sphygmomanometer according to the
British Hypertension Society protocol [16]. The partici-
pants were advised to avoid caffeinated beverages and to
exercise for ≥ 30 min before the measurement. During the
measurement, the participants were seated with their arms
supported at the level of their hearts. The mean of three
BP measurements was calculated and used in all analyses.
Weight and height were measured to the nearest
0.1 kg and 0.1 cm, respectively, with the participants in
lightweight clothing without shoes. The body mass
index (BMI) was calculated as weight in kilograms di-
vided by the square of the height in meters. Waist
circumference (WC) was measured at the umbilicus to
the nearest 0.1 cm while the participants were standing
following a normal expiration.
Fasting blood samples were collected in the morning
after ≥ 8 h of fasting for all participants. Blood samples
were obtained from an antecubital vein using BD Vacutai-
ner tubes containing EDTA (Becton, Dickinson and Co.,
Franklin Lakes, NJ, USA). Serum was subsequently
isolated from whole blood, and all serum samples were
frozen at −20 °C for testing at a central, certified labora-
tory. Fasting blood glucose (FBG), total cholesterol (TC),
triglycerides (TG), SUA, and other routine blood bio-
chemical indices were analyzed enzymatically on an auto-
Analyzer (Olympus AU640; Olympus, Kobe, Japan, or
Bayer RA-XT; Bayer Diagnostics, Tarrytown, NY, USA)
using kits (Bayer Diagnostics). The laboratory measure-
ments were calibrated and verified following analysis of
biochemical indices and the results met the national stan-
dards of measurement (CNAS certificate of accreditation
No.L0467, quality index U = 0.006 (k = 2)).
Twelve-lead resting, ten-second electrocardiograms
(ECGs) were performed on all participants by well-trained
cardiologists using an electrocardiography machine (MAC
5500; GE Healthcare, Little Chalfont, Buckinghamshire,
UK). The results were analyzed automatically by the
MUSE Cardiology Information System (version 7.0.0; GE
Healthcare). ECG-based diagnoses of AF were confirmed
by at least two independent cardiologists.
Echocardiograms were obtained using a commercially
available Doppler echocardiograph (Vivid; GE Healthcare)
with a 3.0-MHz transducer. The transthoracic echocardio-
gram included M-mode, two-dimensional, spectral and
color Doppler with subjects in the supine position. Echo-
cardiogram analyses and readings were performed by
three doctors specialized in echocardiography, and two
other specialists were called in if questions or uncertainty
arose. Measurements were performed according to the
recommendations of the American Society of Echocardi-
ography. M-mode images were used to measure and
calculate the left ventricular ejection fraction (LVEF) [17].
Definitions
AF was diagnosed based on a previous history of AF
(previously diagnosed by a physician) and/or evidence of
AF on the ECG (absence of consistent P waves, presence
of rapid irregular f waves with a frequency of 350–600
beats per minute, and an irregular ventricular response).
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Left ventricular hypertrophy diagnosed by ECG (ECG-
LVH) was identified using the Cornell Criteria expressed
as voltage and QRS duration product: (RaVL + SV3) ×
QRS duration > 2,440 mm*ms in men and (RaVL + SV3 +
8 mm) ×QRS duration > 2,440 mm*ms in women [18].
Left ventricular systolic dysfunction was defined as an
LVEF < 0.5 based on M-mode echocardiography. Hyper-
uricemia was defined as an SUA level > 7.0 mg/dL in men
and > 5.7 mg/dL in women, based on the NHANES-III la-
boratory definitions [19].
Statistical analysis
All statistical analyses were performed using SPSS 17.0
software (SPSS Inc., Chicago, IL, USA). Differences
between groups were compared using a two-tailed
Student’s t-test for continuous variables and a χ2 test
for categorical variables. The age- and gender-specific
prevalences of AF among participants with both normal
SUA levels and hyperuricemia were calculated, and
univariate and multivariate logistic regression analyses
were performed to estimate the crude and independent
association between SUA and the presence of AF. Inter-
action regression models were used to test the difference
in the association of SUA with AF prevalence between
men and women. Data are expressed as odds ratio (OR)
and 95 % confidence interval (CI), mean ± standard devi-
ation, or frequency and percentage; a P < 0.05 was consid-
ered as statistically significant.
Results
Characteristics of the study population
Of the original 11,956 participants, 618 had incomplete
data and were excluded from the analysis, leaving a total
of 11,338 participants (5,170 men and 6,168 women)
with a mean age of 53.8 years. The subjects with hyper-
uricemia were older than those with normal SUA levels
(P < 0.001), and there was a higher percentage of men
than women in this group (P < 0.001) (Table 1). Partici-
pants with hyperuricemia had significantly higher WCs,
BMIs, systolic and diastolic BPs, FBG, TC, and TG levels
(all Ps < 0.001). The hyperuricemia group also had a
higher percentage of alcohol drinkers and had a higher
prevalence of MI, and ECG-LVH than the normal SUA
level group (all Ps < 0.001). The prevalence of AF was
significantly higher in participants with hyperuricemia
than those with normal SUA (P < 0.001).
Prevalence of AF by SUA level
There were 139 participants with AF, and the age-
specific prevalence of AF by SUA level is summarized in
Fig. 1. Among these AF cases, 72 were self-reported, 45
were ECG-diagnosed, and 22 were both. The prevalence
of AF rose steeply with advancing age and was higher in
the group with hyperuricemia than in the group with
normal SUA levels at every age. The trends in AF preva-
lence with age were similar between men and women.
Association between SUA and AF
The association between hyperuricemia and AF was
examined by logistic regression analysis (Table 2). Both
men and women with hyperuricemia had a higher
prevalence of AF than those with normal SUA levels (P <
0.001 for men, P = 0.010 for women and P < 0.001 for
total). After adjusting for other cardiovascular and AF risk
factors, including age, gender, WC, BMI, systolic and dia-
stolic BP, FBG, TC, TG, smoking, drinking, history of MI,
low LVEF, ECG-LVH and familial history of AF, the inde-
pendent association was significant in men (P = 0.003)
and in men and women together (P = 0.003), but not in
women alone (P = 0.235). However, P > 0.05 was observed
for the association of AF with hyperuricemia between
men and women. Similar associations were found be-
tween SUA as a continuous variable and AF prevalence
(Table 3).
Discussion
The results of this study demonstrate that men and
women with hyperuricemia in a rural Chinese popula-
tion have a significantly higher prevalence of AF than
those with normal SUA levels. The AF prevalence
increases with advancing age in both men and women,
Table 1 Characteristics of the study population
Variable Normal SUA level Hyperuricemia P
(n = 9,909) (n = 1,429)
Age, y 53.7 ± 10.5 54.9 ± 10.9 <0.001
Sex, male 4396 (44.4) 774 (54.2) <0.001
BMI, kg/m2 24.6 ± 3.6 26.4 ± 3.9 <0.001
WC, cm 81.6 ± 9.6 87.9 ± 9.9 <0.001
SBP, mmHg 141.2 ± 23.4 145.9 ± 23.8 <0.001
DBP, mmHg 81.5 ± 11.5 85.7 ± 12.7 <0.001
FBG, mmol/L 5.88 ± 1.65 6.05 ± 1.47 <0.001
TC, mmol/L 5.18 ± 1.06 5.58 ± 1.23 <0.001
TG, mmol/L 1.53 ± 1.30 2.41 ± 2.34 <0.001
Current smoker 3478 (35.1) 502 (35.1) 0.982
Current drinker 2107 (21.3) 418 (29.3) <0.001
History of MI 101 (1.0) 30 (2.1) <0.001
LVEF < 0.5 1126 (11.8) 144 (10.4) 0.131
ECG-LVH 799 (8.1) 215 (15.0) <0.001
AF 104 (1.0) 35 (2.4) <0.001
Family history of AF 306 (3.1) 38 (2.7) 0.377
Note: data are expressed as mean ± standard deviation or n (%)
AF atrial fibrillation, BMI body mass index, DBP diastolic blood pressure,
ECG-LVH left ventricular hypertrophy detected by electrocardiography, FBG
fasting blood glucose, LVEF left ventricular ejection fraction, MI myocardial
infarction, SBP systolic blood pressure, SUA serum uric acid, TC total cholesterol,
TG triglycerides, WC waist circumference
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Fig. 1 Age-specific prevalence of atrial fibrillation by serum uric acid levels. The prevalence of AF in men (top), women (center), and the total
population (bottom)
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but the independent association with SUA is only
observed in the total population and in men after adjust-
ing for other cardiovascular risk factors. Our finding that
hyperuricemia was positively associated with the AF
prevalence in the general population was consistent with
previous studies [9–13]. However, in our current study,
the independent association was only observed in men
but not in women, which was inconsistent with previous
findings in Japan [9]. A recent meta-analysis that in-
cluded both cross-sectional and cohort studies, also
reported a positive relationship between SUA and the
prevalence of AF [20]. Population-based prospective
cohort studies showed that baseline SUA was associated
with an increased risk of AF in both genders [14, 15]. It
is possible that race and lifestyle influenced the results
of our study, as Asians and African-Americans have a
lower prevalence of AF than other races [21], and our
study population consisted of people living exclusively in
rural areas, most of whom routinely performed heavy
physical labor.
We also tested the difference in the association of
SUA with AF between men and women by interaction
regression models. However, the effect of gender on the
association was not statistically significant with Ps > 0.05.
This inconsistency may be due to low AF prevalence
and the small sample size. Indeed, the positive associ-
ation between SUA and AF might also exist in women
(even though this might not be statistically significant).
In our current study, AF was diagnosed based on a
previous history of physician-diagnosed AF and/or evi-
dence of AF using the ECG. This diagnostic approach
has been utilized in previous studies [9, 22]. Self-
reported AF history was previously used as a method
for the diagnosis of AF. However, it is likely that this
approach gave rise to an unintentional bias.
The major clinical risk factors for AF are advancing
age, male gender, hypertension, diabetes, obesity, heart
failure, valve disease, MI, smoking, and alcohol con-
sumption, but biomarkers such as B-type natriuretic
peptide [23, 24] and C-reactive protein [25, 26] also
correlate with AF. Systemic inflammation indicated by
an elevated level of C-reactive protein is associated with
the incidence and persistence of AF [26, 27]. SUA regu-
lates some critical proinflammatory pathways [28] and
correlates with several inflammatory markers [29]. In-
flammation could cause oxidative damage to the atrium
that might contribute to electrical remodeling and
increase the incidence of AF [30]. SUA may therefore
be another useful biomarker for the condition, though
Table 2 Hyperuricemia and the prevalence of atrial fibrillation
Group Total AF Unadjusted model Adjusted modela
(n) n (%) OR (95 % CI) P OR (95 % CI) P
Men
Normal SUA levels 4,396 44 (1.0) 1 <0.001 1 0.003
Hyperuricemia 774 20 (2.6) 2.62 (1.54–4.48) 2.55 (1.38–4.71)
Women
Normal SUA levels 5,513 60 (1.1) 1 0.010 1 0.235*
Hyperuricemia 655 15 (2.3) 2.13 (1.20–3.77) 1.46 (0.78–2.72)
Total
Normal SUA levels 9,909 104 (1.0) 1 <0.001 1 0.003
Hyperuricemia 1,429 35 (2.4) 2.37 (1.61–3.49) 1.94 (1.26–3.00)
AF atrial fibrillation, CI confidence interval, OR odds ratio, SUA serum uric acid
*P = 0.200 for gender difference
aAdjusted for age, gender, body mass index, waist circumference, systolic and diastolic blood pressure, fasting blood glucose, total cholesterol and triglyceride
levels, smoking, drinking, myocardial infarction, low left ventricular ejection fraction, left ventricular hypertrophy detected by electrocardiography, and family
history of AF
Table 3 Serum uric acid levels and the prevalence of atrial
fibrillation
Group Unadjusted model Adjusted modela
OR (95 % CI) P OR (95 % CI) P
Men
SUA, per mg/dl 1.30 (1.13–1.50) <0.001 1.26 (1.08–1.47) 0.004
Women
SUA, per mg/dl 1.31 (1.11–1.55) 0.002 1.11 (0.92–1.33) 0.291*
Total
SUA, per mg/dl 1.25 (1.13–1.38) <0.001 1.20 (1.06–1.36) 0.003
AF atrial fibrillation, CI confidence interval, OR odds ratio, SUA serum uric acid
*P = 0.302 for gender difference
aAdjusted for age, gender, body mass index, waist circumference, systolic and
diastolic blood pressure, fasting blood glucose, total cholesterol and
triglyceride levels, smoking, drinking, myocardial infarction, low left ventricular
ejection fraction, left ventricular hypertrophy detected by electrocardiography,
and family history of AF
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the mechanisms by which SUA influences AF risk are
unclear.
A limitation of this study is the cross-sectional design
and it is not clear whether lowering SUA levels would
also decrease the incidence and prevalence of AF. In
addition, the number of people who had hyperuricemia
in our study was small, and the prevalence of AF in
some subgroups was zero or too small to measure for
statistical significance. The association between SUA and
AF in our study may also have been affected by con-
founding risk factors for AF (i.e., hypertension, diabetes,
and dislipidemia), which also occur with hyperuricemia.
However, results from the univariate and multivariate
logistic regression analyses indicate that SUA is an inde-
pendent risk factor for AF. But, further cohort studies
need to be conducted to determine whether reducing
SUA levels reduce AF incidence and prevalence.
Conclusions
Men and women in rural China ≥ 35 years of age with
hyperuricemia have a significantly higher prevalence of
AF than those with normal SUA levels. Hyperuricemia is
independently associated with the prevalence of AF after
adjusting for various cardiovascular risk factors.
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